Mark J. Alles - May 24, 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
Director
Signature
/s/ Annette North, Attorney-in-Fact
Stock symbol
TPTX
Transactions as of
May 24, 2021
Transactions value $
$0
Form type
4
Date filed
5/26/2021, 04:50 PM
Next filing
Jun 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Award $0 +17K $0.00 17K May 24, 2021 Common Stock 17K $70.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of 36 successive equal monthly installments over the three-year period measured from the date of grant.